Literature DB >> 29037856

Platelet CD40 Mediates Leukocyte Recruitment and Neointima Formation after Arterial Denudation Injury in Atherosclerosis-Prone Mice.

Rong Jin1, Adam Y Xiao2, Zifang Song3, Shiyong Yu3, Jarvis Li4, Mei-Zhen Cui5, Guohong Li6.   

Abstract

The role of platelets in the development of thrombosis and abrupt closure after angioplasty is well recognized. However, the direct impact of platelets on neointima formation after arterial injury remains undetermined. Herein, we show that neointima formation after carotid artery wire injury reduces markedly in CD40-/- apolipoprotein E-deficient (apoE-/-) mice but only slightly in CD40 ligand-/-apoE-/- mice, compared with apoE-/- mice. Wild-type and CD40-deficient platelets were isolated from blood of apoE-/- and CD40-/-apoE-/- mice, respectively. The i.v. injection of thrombin-activated platelets into CD40-/-apoE-/- mice was performed every 5 days, starting at 2 days before wire injury. Injection of wild-type platelets promoted neointima formation, which was associated with increased inflammation by stimulating leukocyte recruitment via up-regulation of circulating platelet surface P-selectin expression and the formation of platelet-leukocyte aggregates. It was also associated with further promoting the luminal deposition of platelet-derived regulated on activation normal T cell expressed and secreted/chemokine (C-C motif) ligand 5 and expression of monocyte chemoattractant protein-1 and vascular cell adhesion molecule 1 in wire-injured carotid arteries. Remarkably, all these inflammatory actions by activated platelets were abrogated by lack of CD40 on injected platelets. Moreover, injection of wild-type platelets inhibited endothelial recovery in wire-injured carotid arteries, but this effect was also abrogated by lack of CD40 on injected platelets. Results suggest that platelet CD40 plays a pivotal role in neointima formation after arterial injury and might represent an attractive target to prevent restenosis after vascular interventions.
Copyright © 2018 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29037856      PMCID: PMC5745524          DOI: 10.1016/j.ajpath.2017.09.007

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  48 in total

1.  CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury.

Authors:  Guohong Li; John M Sanders; Melissa H Bevard; Zhiqi Sun; James W Chumley; Elena V Galkina; Klaus Ley; Ian J Sarembock
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

Review 2.  CD154 and its receptors in inflammatory vascular pathologies.

Authors:  Ghada S Hassan; Yahye Merhi; Walid M Mourad
Journal:  Trends Immunol       Date:  2009-03-11       Impact factor: 16.687

3.  Interleukin 1 receptor 1 and interleukin 1β regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans.

Authors:  Lea M Beaulieu; Elaine Lin; Eric Mick; Milka Koupenova; Ellen O Weinberg; Carolyn D Kramer; Caroline A Genco; Kahraman Tanriverdi; Martin G Larson; Emelia J Benjamin; Jane E Freedman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-01-23       Impact factor: 8.311

4.  Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.

Authors:  Valerio Sanguigni; Pasquale Pignatelli; Luisa Lenti; Domenico Ferro; Alfonso Bellia; Roberto Carnevale; Manfredi Tesauro; Roberto Sorge; Renato Lauro; Francesco Violi
Journal:  Circulation       Date:  2005-02-01       Impact factor: 29.690

Review 5.  CD40 ligand: a neo-inflammatory molecule in vascular diseases.

Authors:  Ghada S Hassan; Yahye Merhi; Walid Mourad
Journal:  Immunobiology       Date:  2011-04-07       Impact factor: 3.144

6.  Soluble CD40 ligand induces beta3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling.

Authors:  K S Srinivasa Prasad; Patrick Andre; Ming He; Ming Bao; Jeanne Manganello; David R Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

Review 7.  Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases.

Authors:  Janine M van Gils; Jaap Jan Zwaginga; Peter L Hordijk
Journal:  J Leukoc Biol       Date:  2008-10-23       Impact factor: 4.962

8.  Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production.

Authors:  C M Hawrylowicz; G L Howells; M Feldmann
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

9.  Platelet PI3Kγ Contributes to Carotid Intima-Media Thickening under Severely Reduced Flow Conditions.

Authors:  Cuiping Wang; Rong Jin; Anil Nanda; Jinchuan Yan; Guohong Li
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

10.  Roles of the kinase TAK1 in CD40-mediated effects on vascular oxidative stress and neointima formation after vascular injury.

Authors:  Zifang Song; Xiaolei Zhu; Rong Jin; Cuiping Wang; Jinchuan Yan; Qichang Zheng; Anil Nanda; D Neil Granger; Guohong Li
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

View more
  3 in total

1.  PI3Kγ (Phosphoinositide 3-Kinase-γ) Inhibition Attenuates Tissue-Type Plasminogen Activator-Induced Brain Hemorrhage and Improves Microvascular Patency After Embolic Stroke.

Authors:  Rong Jin; Adam Y Xiao; Jarvis Li; Min Wang; Guohong Li
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

Review 2.  Modelling of atherosclerosis in genetically modified animals.

Authors:  Natalia V Mushenkova; Volha I Summerhill; Yulia Yu Silaeva; Alexey V Deykin; Alexander N Orekhov
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

Review 3.  Cyclic Nucleotide-Directed Protein Kinases in Cardiovascular Inflammation and Growth.

Authors:  Nathan A Holland; Jake T Francisco; Sean C Johnson; Joshua S Morgan; Troy J Dennis; Nishitha R Gadireddy; David A Tulis
Journal:  J Cardiovasc Dev Dis       Date:  2018-01-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.